Table 2 Recommendations for initial therapy of primary and CAPD-associated peritonitis.
| Diagnosis | Likely organisms | Initial therapy | Level of evidence | Strength of recommenddation |
|---|---|---|---|---|
| Spontaneous bacterial peritonitis (mostly liver cirrhosis associated) | Escherichia coli | Ceftriaxon | 3 | A |
| Enterococci | Acylaminop enicillin/BLI | 3 | A | |
| Klebsiella spp. | Ciprofloxacin* | 3 | A | |
| Levofloxacin* | 3 | B | ||
| CAPD - associated peritonitis |
S. aureus Enterococci Other Streptococci Escherichia coli | Cephalosporin group 2 with/without Ciprofloxacin* | 3 | A |
| Enterobacteriaceae | Vancomycin + Gentamicin | 3 | A | |
|
Pseudomonas Acinetobacter | See Table 5 | |||
| MRSA, VRE, ESBL | See Table 5 | |||
| Candida sp. | See Table 6 |